Healthcare -
Biotechnology - NASDAQ - US
$ 4.815
-0.926 %
$ 273 M
Market Cap
-5.66
P/E
DSGN - STOCK-BASED COMPENSATION
Stock-based Compensation DSGN - Design Therapeutics, Inc.
13.1 M
LAST VALUE
67.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR